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ABSTRACT
Introduction: Elderly patients commonly use over-the-counter (OTC) medications to
self-manage pain symptoms. Medications such as non-steroidal anti-inflammatory
drugs (NSAIDs), acetaminophen, and topical analgesics are readily available and may
seem harmless to patients. In the growing population of those 65 years and older,
providers need to inquire about OTC medication use due to the increased risk for
adverse reactions in this population. Complications related to these medications can be
worsened by chronic disease, variable metabolism, and polypharmacy, which become
more common in older adults.
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Methods: A survey was created to determine the prevalence and habits of OTC use in the
central Appalachian population, and the potential harms related to provider awareness,
chronic disease, and polypharmacy.
Results: Of surveyed Appalachian seniors (n = 307), 86.3% take OTC medications. Of
these, 57.4% report that they do not tell their provider, and 51.3% do not take the
medication as directed. Within this population, 19.2% of those on blood thinners, 22.4%
of those with hypertension, 34.8% of those with chronic kidney disease, and 30.6% of
those with gastrointestinal issues not only use NSAIDs but do not inform their physician
nor follow the packaging instructions.
Discussion: Potential complications of NSAID use related to these medical comorbidities
are well known. Providers need to regularly ask their older adult patients about the use
of OTC medication to prevent adverse events in this vulnerable population.
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INTRODUCTION
According to 2012 National Projections, 20% of the
population of the United States (US) is projected
to be 65 years and older in 2050.1 This compares to
13% in 2010 and 9.8% in 1970.1 West Virginia (WV)
is expected to exceed this rate with a projection of
22.9% of the population over age 65 in 2030.2 As
this population becomes more extensive, it is crucial
for primary care providers across WV and the US to
identify risks impacting older patients. This includes
the risk of over-the-counter (OTC) medications such
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as non-steroidal anti-inflammatory drugs (NSAIDs),
acetaminophen, and topical analgesics.
NSAIDs are of particular importance due to their side
effect profile and availability. The most common side
effect of NSAID use is gastrointestinal symptoms
such as dyspepsia, heartburn, and nausea; however,
those over age 60 have a greater risk of developing
these mild side effects and more severe side effects
such as ulcers.3-7 Another concerning effect involves
renal function. Kidney injury is often dose/durationdependent and reversible; however, the causes of
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chronic renal failure related to NSAID use (interstitial
nephritis or papillary necrosis) occur more commonly
in the older adult population.3,4,6 Poor outcomes
associated with renal injury are increased by the
prevalence of baseline chronic kidney disease (CKD)
in the older adult population due to the natural
decline in glomerular filtration rate with age. Lastly,
NSAIDs act as an inhibitor of platelet aggregation,
leading to increased bleeding risk. This is especially
important with aspirin use as it irreversibly binds to
the cyclooxygenase enzyme and inactivates platelet
aggregation for the lifetime of the platelet (eight to
12 days).7
Acetaminophen use in the older population is also of
interest. The American Geriatric Society recommends
using acetaminophen as a first-line treatment for
mild to moderate chronic pain in the elderly.9,10 While
acetaminophen toxicity is dose-related, its use in
combination with many other OTC formulations
may result in over-dosage (> 4 grams per day).6,11
Acetaminophen is one of the most common causes
of drug-induced liver injury and accounts for 20% of
liver transplants in the US.12 Patient education about
acetaminophen use is beneficial in all age groups but
especially in the older adult population due to their
variable metabolism of the drug.6
According to the National Health Interview Survey of
2016, the prevalence of chronic pain in those 65-84
years of age was 27.6% and was 33.6% in those 85
years and older.13 These patients commonly turn
to OTC analgesics for relief. In a study performed
by Barat, Andreason, and Damsgaard in 2000, it
was estimated that 72% of community-dwelling
elders 75-years and older used OTC medications.14
Another study conducted on older individuals in a
rural community reported that 87% used at least
one OTC medication, and 5.7% took more than five
OTC medications.15 Healthcare providers need to be
aware of the type and extent of their use to anticipate
and prevent side effects and drug interactions in
this vulnerable population.16,17 The purpose of this
study was to estimate the use of OTC analgesics, the
communication to the primary care provider, and
the comorbid risk factors of an older Appalachian
population.
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METHODS
To assess the non-prescription pain medication
habits of older adults (65+ years old), project staff
created and administered a short survey to a nonrandomized sample of consecutively encountered
residents of Kentucky, Ohio, and West Virginia at the
2019 Cabell Huntington Hospital Senior Fair, the
Center for Healthy Aging, and Marshall Health offices
in Barboursville, Lavalette, and Huntington, West
Virginia. It included demographic questions about
gender, age, and county of residence, and binary
yes/no habit questions including notification of
provider, use per labeled instructions, use of blood
thinners, use of hypertensive medications, presence
of kidney disease, and presence of GI disorders.
Fellowship-trained geriatricians and research staff
created the survey and piloted it with a small group
of older adults for understanding and accuracy. Over
96% of the questions that were verifiable within the
electronic health record were found accurate.
Statistical analyses were performed using SAS9.4. A
binary logistic regression model was built with the
targeted variable: “whether the physician was aware
of the patient’s analgesic use.” Predictor variables
were age, gender, residing county, adherence to
the drug label, blood thinner use, blood pressure
medication use, presence of kidney disease,
presence of GI pathology, and type of OTC analgesic
used. Except for the continuous variable age, all
other variables were treated as categorical variables.
The effects significantly associated with the target
variable (p<0.05) were identified, and the odds ratio
and their Wald confidence intervals were reported.
The ROC curve evaluated the performance of the
model. This project was approved by Marshall IRB
(#1177330-6).
RESULTS
Table 1 details the demographics of the 307
surveyed patients, broken down into specific groups
for OTC analgesic used and combined into NSAID,
non-NSAID, and no analgesic used groupings. When
combined by Cabell, Lincoln, and other counties,
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TABLE 1: Demographics of the 307 senior patients surveyed is the numerator on the top.
* calculated by simple T-Table Test.
^calculated by logistic regression.

combined groupings are similar for age (chi-square
0.6888; p-value 0.4066) and county (chi-square
5.062; p-value 0.2810). Differences were seen for
gender (chi-square 22.7891; p-value 0.000011), with
women most likely to use OTC analgesia, specifically
non-NSAIDs, and least likely to reply “none” to the
OTC analgesic question.
Groupings of no medications, NSAIDs, and no
NSAIDs differed only in following the prescribing
label (chi-square 64.6961; p-value < 0.00001). There
were no differences in comorbidities between the
groups (Table 2).
Independent factors affecting the likelihood of the
patient informing their physician about their OTC
analgesic use are located in Figure 1. Independent
factors associated with an increased chance of
disclosing the medication included following the
labeled instructions (OR = 0.195, CI = 0.094-0.406)
and anticoagulant use (OR = 0.420, CI = 0.212-0.824).
Variables associated with a decreased chance of
disclosing OTC analgesic use to their provider are
living outside Cabell County (OR = 2.006; CI = 1.1303.560), having GI pathology (OR = 2.103; CI = 1.1663.794), and use of acetaminophen (OR = 2.229; CI =
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1.251-3.973). The ROC curve was scored as 0.7573.
When the data set for OTC NSAID use was analyzed,
negative answers for both the “informing the
physician” and “following the label” questions
revealed that a startling number of patients with
vulnerable comorbidities used unknown amounts
of NSAIDs without their physician’s knowledge.
This was true for patients on blood thinners, with
hypertension, with kidney disease, and with GI
pathology at levels of 19.2%, 22.4%, 34.8%, and
30.6%, respectively.
DISCUSSION
NSAIDs, acetaminophen, and herbal or topical
analgesics are commonly used OTC medications.12,13
Due to chronic medical problems that require
multiple medications, the elderly population is
more vulnerable to the dangers of OTC analgesic
use. Knowledge of this use in an older Appalachian
adult population provides beneficial information for
practice improvement. A large population of older
adults in central Appalachia was surveyed regarding
their use of OTC analgesics and comorbid conditions
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TABLE 2: Habits and co-morbidities of the patients surveyed.
* does not include patients reporting no OTC analgesic use.
^calculated by logistic regression

FIGURE 1: Factors affecting patients’ likelihood of disclosing OTC medication use.
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to better understand this. Out of 307 participants,
265 (86.3%) reported using OTC analgesics. The
prevalence of their use should alert primary care
physicians to ask all patients specifically about their
OTC analgesic habits. Factors associated with an
increased likelihood of informing their providers of
OTC medication use were identified. Participants
who followed labeled instructions and those on
an anticoagulant were more likely to discuss OTC
medications with their provider. Factors associated
with a decreased likelihood of disclosing OTC
medication use were residence outside of Cabell
County, having GI pathology, and the use of
acetaminophen.
While these correlations are important to note, it is
critical to understand the number of participants
who take OTC medications with potential side
effects related to their vulnerable chronic diseases.
A well-known adverse effect of NSAID use is
gastrointestinal ulcers, an increased risk for the older
adult population.3-7 Our study indicated that 30.6%
of participants on NSAIDs with GI issues neither
informed their provider about these medications nor
followed medication instructions. This is significant
for multiple reasons. The first concern is the
relationship to the prescribing cascade. As patients
begin taking an NSAID regularly or even over the
recommended dose in the self-treatment of chronic
pain, they can develop gastrointestinal ulcers and
GI discomfort related to the NSAID. This leads to
the prescription of medication for heartburn, which
contributes to the already well-known problem of
polypharmacy in our older adult patients. Secondly,
nonselective NSAIDs contribute to ulcer formation
by inhibiting prostaglandin synthesis and acting as
an anti-platelet agent.7 This combination leads to
increased bleeding risk in a vulnerable population.
It is also essential to assess for the use of NSAIDs with
a prescribed anticoagulant. These anticoagulants
such as warfarin, apixaban, dabigatran, enoxaparin,
and heparin are all listed as Category D with
recommendations to consider therapy modification
due to increased risk of bleeding.8 Of this patient
population, twenty-six admitted to using blood
thinner with NSAIDs, and five (19.2%) of those
did not inform their provider and did not take
them according to instructions (Table 3). Again,
by acting as an anti-platelet agent, the risk of
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significant bleeding in patients taking prescription
anticoagulants is greater. Therefore, it is important to
instruct patients on the avoidance of OTC NSAIDs.
Finally, chronic diseases such as CKD and
hypertension (HTN) can worsen with the use of
NSAIDs.3,4,7 Twenty-three of the participants told
by their doctor that they have CKD also took
unmonitored NSAIDs. Approximately one-third
of those who have CKD and use NSAIDs did not
tell their doctor and did not use the medication
according to instructions. Eighty-five of the
participants have a diagnosis of HTN and use NSAIDs.
Approximately one-fifth of those who have HTN and
use NSAIDs neither told their doctor about their use
nor used the medication according to instructions.
NSAIDs should be avoided in CKD, which is more
prevalent in the older adult population due to
natural decline with age. It is also recommended
that NSAIDs be avoided in those with HTN as they
can cause an increase in blood pressure.7 Providers
should be vigilant when discussing medication
usage in those with CKD and HTN as these adverse
events are more likely to lead to irreversible damage
in the older adult population.
Based on the information gathered in this older adult
Appalachian population, it is clear that OTC use is
not always known to providers. OTC medications are
not benign treatments in the general population and
are even less so in this population. Providers need
to review even brief use of OTC medications and ask
specifically about OTC medications when providing
care to their patients. It may also be beneficial to
educate patients with chronic diseases about the
safe use of OTC medication so that they have options
when mild analgesia occurs.
The primary limitation of this paper is the inability to
verify the medical information on the surveys from
within the medical record. The impact of this is a
potential underestimation of the prevalence of the
queried pathologies within the studied population.
This underreporting could be further exacerbated
by the potential memory issues common in this
population. While it appears that unmonitored
use of OTC NSAIDs poses potential risks, patients’
knowledge of those risks and methods of minimizing
them should be better defined by additional
research.
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As concerning as the NSAID results are, they show
that community-dwelling, Appalachian older adults
are even less likely to inform their physicians that
they are taking acetaminophen. This has its own
deleterious potential effects on health. Another
avenue for future research would be to conduct a
similar population analysis and pair it with medical
conditions that acetaminophen impacts.

5.

6.

CONCLUSION
Most community-dwelling, Appalachian older adults
utilize OTC analgesics for their chronic pain. Most
of these patients, many of whom have a significant
medical comorbidity burden, do not inform their
physicians about their use of these medications.
This study has identified a sizable percentage of
this population with the potentially dangerous
triad of unmonitored NSAID use, lack of adherence
to OTC NSAID product labeling, and comorbidities
adversely affected by NSAIDs. Further efforts need
to be explored in order to protect this vulnerable
population.
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